And our results demonstrated that
significant up-regulation of p21 occurred during the G2/M-phase
arrest in the HepG2 cells as we predicted, which meant that p21
might inhibit the cyclin B1-CDK1 activity to promote G2/M cell
cycle arrest in the germacrone treatment